Swarajya
Our View
Magazine
Headlines
Videos
Books
स्वराज्य
Economy
Culture
Events
Subscribe
Swarajya
Subscribe
Our View
Headlines
Magazine
Swarajya
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Subscriber login
Politics
Economics
Business
Culture
Books & Ideas
World
Defence
Energy & Infrastructure
Science
Technology
Heritage
Videos
Archives
Blogs
News Brief
Indian vaccine
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bhaswati Guha Majumder
Nov 29, 2021 06:23 PM +05:30 IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?
Bhaswati Guha Majumder
Oct 20, 2021 07:16 PM +05:30 IST
ZyCoV-D: India's Homegrown Three-Dose Covid-19 Vaccine For Anyone Over 12, Approved For Emergency Use
Karan Kamble
Aug 21, 2021 05:14 AM +05:30 IST
Bharat Biotech's Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster Dose
Bhaswati Guha Majumder
Aug 16, 2021 05:01 PM +05:30 IST
What We Know About Union Health Minister's Meeting With WHO Chief Scientist
Bhaswati Guha Majumder
Aug 14, 2021 05:01 PM +05:30 IST
Ahmedabad Based Zydus Cadila Seeks DCGI Nod For Phase-3 Clinical Trials Of Its COVID-19 Vaccine With 30,000 Volunteers
Swarajya Staff
Dec 25, 2020 09:32 AM +05:30 IST
Load More